X-112779270-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The ENST00000371959.9(AMOT):āc.2884T>Gā(p.Ser962Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000894 in 637,562 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000371959.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMOT | NM_001113490.2 | c.2884T>G | p.Ser962Ala | missense_variant | 13/14 | ENST00000371959.9 | NP_001106962.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMOT | ENST00000371959.9 | c.2884T>G | p.Ser962Ala | missense_variant | 13/14 | 1 | NM_001113490.2 | ENSP00000361027 | P3 | |
AMOT | ENST00000371962.5 | c.2188T>G | p.Ser730Ala | missense_variant | 10/11 | 1 | ENSP00000361030 | A2 | ||
AMOT | ENST00000304758.5 | c.1657T>G | p.Ser553Ala | missense_variant | 11/12 | 1 | ENSP00000305557 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000625 AC: 7AN: 111927Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34209
GnomAD3 exomes AF: 0.0000530 AC: 7AN: 131979Hom.: 0 AF XY: 0.0000237 AC XY: 1AN XY: 42215
GnomAD4 exome AF: 0.0000951 AC: 50AN: 525635Hom.: 0 Cov.: 8 AF XY: 0.0000960 AC XY: 16AN XY: 166653
GnomAD4 genome AF: 0.0000625 AC: 7AN: 111927Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34209
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at